Lasse Hjort Jakobsen

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Survival 69%
3. Lymphoma 62%
4. Population 60%
5. Cohort Studies 56%
6. Non-Hodgkin's Lymphoma 41%
7. Hodgkin Disease 39%
8. Psychotropic Drugs 37%
9. SARS Virus 36%
10. GATA2 Deficiency 34%
11. Burkitt Lymphoma 31%
12. Phototherapy 29%
13. Acute Myeloid Leukemia 29%
14. Denmark 28%
15. Recurrence 26%
16. Jaundice 25%
17. Progression-Free Survival 24%
18. Therapeutics 24%
19. Survivors 22%
20. Bone Density 22%
21. Mortality 22%
22. Neoplasms 21%
23. Newborn Infant 19%
24. Rituximab 19%
25. plerixafor octahydrochloride 18%
26. Infections 17%
27. Light 17%
28. Follicular Lymphoma 17%
29. Peripheral T-Cell Lymphoma 17%
30. Myeloid Progenitor Cells 16%
31. Chimeric Antigen Receptors 16%
32. Alendronate 16%
33. Precision Medicine 16%
34. Bilirubin 15%
35. Assisted Reproductive Techniques 15%
36. Osteoporosis 15%
37. Life Expectancy 14%
38. B-Cell Lymphoma 14%
39. Second Primary Neoplasms 14%
40. Homologous Transplantation 14%
41. Survivorship 13%
42. Drug Prescriptions 13%
43. Cell- and Tissue-Based Therapy 13%
44. Independent Living 12%
45. Accidental Falls 12%
46. Counseling 12%
47. Anxiety 12%
48. Depression 12%
49. Precursor Cell Lymphoblastic Leukemia-Lymphoma 12%